483 Document: Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical, Dec 20, 2019

FDANews 483 Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical Dec 20 2019 top
Erika V. Butler FDA Investigator

On Dec 20, 2019, the FDA inspected Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical's Los Angeles site. Explore the inspectional observations.